211 related articles for article (PubMed ID: 26649139)
1. Oxidative Stress and Mitochondrial Activation as the Main Mechanisms Underlying Graphene Toxicity against Human Cancer Cells.
Jarosz A; Skoda M; Dudek I; Szukiewicz D
Oxid Med Cell Longev; 2016; 2016():5851035. PubMed ID: 26649139
[TBL] [Abstract][Full Text] [Related]
2. Bioapplications of graphene constructed functional nanomaterials.
Gulzar A; Yang P; He F; Xu J; Yang D; Xu L; Jan MO
Chem Biol Interact; 2017 Jan; 262():69-89. PubMed ID: 27876601
[TBL] [Abstract][Full Text] [Related]
3. Degradation of Mitochondria and Oxidative Stress as the Main Mechanism of Toxicity of Pristine Graphene on U87 Glioblastoma Cells and Tumors and HS-5 Cells.
Jaworski S; Strojny B; Sawosz E; Wierzbicki M; Grodzik M; Kutwin M; Daniluk K; Chwalibog A
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717385
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration.
Zhou H; Zhang B; Zheng J; Yu M; Zhou T; Zhao K; Jia Y; Gao X; Chen C; Wei T
Biomaterials; 2014 Feb; 35(5):1597-607. PubMed ID: 24290441
[TBL] [Abstract][Full Text] [Related]
5. Effect of graphene on growth of neuroblastoma cells.
Park HB; Nam HG; Oh HG; Kim JH; Kim CM; Song KS; Jhee KH
J Microbiol Biotechnol; 2013 Feb; 23(2):274-7. PubMed ID: 23412072
[TBL] [Abstract][Full Text] [Related]
6. Interactions of graphene with mammalian cells: Molecular mechanisms and biomedical insights.
Zhang B; Wei P; Zhou Z; Wei T
Adv Drug Deliv Rev; 2016 Oct; 105(Pt B):145-162. PubMed ID: 27569910
[TBL] [Abstract][Full Text] [Related]
7. Graphene-based materials: The missing piece in nanomedicine?
Tabish TA
Biochem Biophys Res Commun; 2018 Oct; 504(4):686-689. PubMed ID: 30213629
[TBL] [Abstract][Full Text] [Related]
8. Graphene-like two-dimensional layered nanomaterials: applications in biosensors and nanomedicine.
Yang G; Zhu C; Du D; Zhu J; Lin Y
Nanoscale; 2015 Sep; 7(34):14217-31. PubMed ID: 26234249
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility and toxicology effects of graphene oxide in cancer, normal, and primary immune cells.
Martinez Paino IM; Santos F; Zucolotto V
J Biomed Mater Res A; 2017 Mar; 105(3):728-736. PubMed ID: 27770563
[TBL] [Abstract][Full Text] [Related]
10. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
11. Developing the next generation of graphene-based platforms for cancer therapeutics: The potential role of reactive oxygen species.
Tabish TA; Zhang S; Winyard PG
Redox Biol; 2018 May; 15():34-40. PubMed ID: 29197802
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene.
Sasidharan A; Sivaram AJ; Retnakumari AP; Chandran P; Malarvizhi GL; Nair S; Koyakutty M
Adv Healthc Mater; 2015 Apr; 4(5):679-84. PubMed ID: 25586821
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in aptasensors based on graphene and graphene-like nanomaterials.
Ping J; Zhou Y; Wu Y; Papper V; Boujday S; Marks RS; Steele TW
Biosens Bioelectron; 2015 Feb; 64():373-85. PubMed ID: 25261843
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine.
Zhang Y; Petibone D; Xu Y; Mahmood M; Karmakar A; Casciano D; Ali S; Biris AS
Drug Metab Rev; 2014 May; 46(2):232-46. PubMed ID: 24506522
[TBL] [Abstract][Full Text] [Related]
15. Protein corona-mediated mitigation of cytotoxicity of graphene oxide.
Hu W; Peng C; Lv M; Li X; Zhang Y; Chen N; Fan C; Huang Q
ACS Nano; 2011 May; 5(5):3693-700. PubMed ID: 21500856
[TBL] [Abstract][Full Text] [Related]
16. Graphene-based nanomaterials for drug delivery and tissue engineering.
Goenka S; Sant V; Sant S
J Control Release; 2014 Jan; 173():75-88. PubMed ID: 24161530
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of graphene: recent advances and future perspective.
Zhou R; Gao H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(5):452-74. PubMed ID: 24957946
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional hybrid nanopatches of graphene oxide and gold nanostars for ultraefficient photothermal cancer therapy.
Nergiz SZ; Gandra N; Tadepalli S; Singamaneni S
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16395-402. PubMed ID: 25152960
[TBL] [Abstract][Full Text] [Related]
19. Assessing in vivo toxicity of graphene materials: current methods and future outlook.
Ma Y; Shen H; Tu X; Zhang Z
Nanomedicine (Lond); 2014 Jul; 9(10):1565-80. PubMed ID: 25253502
[TBL] [Abstract][Full Text] [Related]
20. Application of Graphene and its Derivatives in Cancer Diagnosis and Treatment.
Ghanbarzadeh S; Hamishehkar H
Drug Res (Stuttg); 2017 Dec; 67(12):681-687. PubMed ID: 28898912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
